View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Ru...

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CELEBRATION, Fla., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has granted options to purchase an aggregate of 53,000 shares of the Company’s common stock (the “Inducement Awards”) to three new employees pursuant to the Company’s 2023 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”)....

Paycom Software Inc: 1 director

A director at Paycom Software Inc sold 2,192 shares at 165.849USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

 PRESS RELEASE

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; ...

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD CELEBRATION, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced the appointment of Alicia Secor to the Company’s Board of Directors (Board). The Company also announced the retirement of director Wendy Dixon, PhD, effective today. "We are pleased to welcome Alicia to our Board at this important juncture, as her expe...

 PRESS RELEASE

Barnes & Noble Education Announces Preliminary Full-Year Fiscal 2025 a...

Barnes & Noble Education Announces Preliminary Full-Year Fiscal 2025 and Year-to-Date Fiscal 2026 Unaudited Financial Results Company Announces the Conclusion and Findings of Internal Investigation Releases Preliminary FY2025 and First Half 2026 Results First Day Complete Enrollment for Fall 2025 Estimated to Grow 24%* Board of Directors Pleased with Revenue Growth & Strong Improvements in Operating Results and Balance Sheet FLORHAM PARK, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE: BNED), (“Barnes & Noble Education,” “BNED,” “the Company,” “we...

 PRESS RELEASE

Zevra Therapeutics, Inc. Announces CFO Transition

Zevra Therapeutics, Inc. Announces CFO Transition CELEBRATION, Fla., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, announced today that its Chief Financial Officer and Treasurer, R. LaDuane Clifton, will be stepping down from his position with the Company, effective December 31, 2025, in order to pursue other professional opportunities. "Since joining the Company in 2015, LaDuane has provided steady leadership and invaluable guidance, leavin...

 PRESS RELEASE

Zevra Reports Third Quarter 2025 Financial Results and Corporate Updat...

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update 2025 EPS of $(0.01) Q3 2025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 million Company to host conference call and webcast TODAY, November 5, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results for the three and nine months ended September 30, 2025. "Zevra is well-posi...

 PRESS RELEASE

Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovat...

Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference CELEBRATION, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in a fireside discussion at Guggenheim's 2nd Annual Healthcare Innovation Conference in Boston, MA on Wednesday, November 12, 2025, at 11:30 a.m. ET. Additionally, management will be available for one-on-one mee...

 PRESS RELEASE

Zevra Therapeutics Announces Details for Q3 2025 Financial Results Cal...

Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call - Company will host conference call at 4:30 p.m. ET on Wednesday, November 5, 2025 CELEBRATION, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the third quarter 2025 on Wednesday, November 5, 2025, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m....

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 11, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Ru...

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has granted options to purchase an aggregate of 38,000 shares of the Company’s common stock (the “Inducement Awards”) to two new employees pursuant to the Company’s 2023 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”). E...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 4, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Barnes & Noble College Launches Campus to Career, a NEW Offering to He...

Barnes & Noble College Launches Campus to Career, a NEW Offering to Help Students Build Real-World Skills to Enter the Workforce BASKING RIDGE, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Barnes & Noble College (BNC), a  (NYSE: BNED) company and leading solutions provider for higher education, today announced the launch of Campus to Career — a new offering designed to equip college students with the tools, resources and insights they need to help transition from the classroom to the workplace. Campus to Career offers a curated collection of products available both in-store and online, along...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: September 27, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 23, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Barnes & Noble College Introduces Room Service – An Innovative Dorm Sh...

Barnes & Noble College Introduces Room Service – An Innovative Dorm Shopping and Delivery Service New service helps students and families skip move-in day stress with guided shopping and curated essentials delivered directly to residence halls BASKING RIDGE, N.J., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Barnes & Noble College (BNC), a  (NYSE: BNED) company and leading solutions provider for higher education, today announced the launch of Room Service, a first-of-its-kind service designed to make shopping and moving-in easier and stress-free for college students and their families. Room Se...

 PRESS RELEASE

Zevra Therapeutics Announces Upcoming Oral Presentation at the Interna...

Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate) MIPLYFFA, the only therapy for Niemann-Pick disease type C (NPC) shown to stop disease progression at 12 months, has been administered to more than 270 patients, representing the largest data set of NPC clinical trial patients OLPRUVA offers the established efficacy and safety of sodium phenylbutyrate in a novel and convenient formula...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 16, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch